StonvexLoading…
StonvexStonvexStonvexCore line items from AXTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $88.33M | $99.36M | $75.80M | $141.12M |
Operating Income | $-21.98M | $-14.80M | $-21.57M | $12.55M |
Net Income | $-21.26M | $-11.62M | $-17.88M | $15.81M |
EPS (Diluted) | $-0.49 | $-0.27 | $-0.42 | $0.37 |
Total Assets | $433.75M | $339.31M | $358.70M | $370.07M |
Total Liabilities | $99.12M | $84.41M | $89.56M | $80.33M |
Cash & Equivalents | $120.27M | $22.83M | $37.75M | $34.95M |
Free Cash Flow OCF − CapEx | $-18.78M | $-17.88M | $-7.07M | $-37.23M |
Shares Outstanding | 55.34M | 45.36M | 44.24M | 43.55M |